Although vitamin D was initially considered a nutrient, it has been recognized that the molecules derived from vitamin D metabolism are best considered as a complex endocrine system. In this review article we summarize the basic concepts regarding vitamin D metabolism, transport, and genomic activity through the vitamin D receptor, facilitating activation or suppression of target genes. We also examine non-genomic actions, biological responses to vitamin D in classic target organs (intestine, bone, kidneys, and parathyroid glands), and in organs and tissues not related to mineral homeostasis.
HolickM.F.. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: FavusM.J. (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.Washington, DC: American Society for Bone and Mineral Research; 2003. pp. 129–37.
4.
ArmasL.A.G., HollisB.W., HeaneyR.P.. Vitamin D2 is much less effective than vitamin D3 in humans.J Clin Endocrinol Metab2004; 89: 5387–91.
5.
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes.Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.Washington DC: National Academies Press; 1999. pp. 71–145.
6.
ViethR.. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.Am J Clin Nutr1999; 69: 842–56.
ReinhartT.A., RambergC.F., HorstR.L.. Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3 and, 1,25-dihydroxyvitamin D2, and its 24 epimer.Arch Biochem Biophys1989; 273: 64–71.
9.
CunninghamJ., MakinH.. How important is vitamin deficiency in uremia?.Nephrol Dial Transplant1997; 12: 16–18.
10.
McKennaM.J., FreaneyR.. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.Osteoporosis Int1998; 8: S3–6.
11.
CannataJ.B., AlonsoC.G.. Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure.Nephrol Dial Transplant2002; 17: 1875–8.
12.
GhazaliA., FardelloneP., PrunaA.. Is low 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriolo?Kidney Int1999; 55: 2169–77.
13.
CoenG., MantellaD., ManniM.. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.Kidney Int2005; 68: 1840–5.
14.
CookeNE, and HaddadJ.G.. Vitamin D binding protein (Gc-globulin).Endocr Rev1989; 10: 294–307.
15.
SpeeckaertM., HuangG., DelangheJ.R., TaesY.E.. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.Clin Chim Acta2006; 372: 33–42.
16.
AndreassenT.K.. The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids.Horm Metab Res2006; 38: 279–90.
17.
NykjaerA., DragunD., WaltherD.. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH)vitamin D3.Cell1999; 96: 507–15.
18.
DussoA., Lopez-HilkerS., RappN., SlatopolskyE.. Extra-renal production of calcitriol in chronic renal failure.Kidney Int1988; 34: 368–75.
19.
DussoA.S., FinchJ., BrownA.. Extrarenal production of calcitriol in normal and uremic humans.J Clin Endocrinol Metab1991; 72: 157–64.
20.
GallieniM., KamimuraS., AhmedA.. Kinetics of monocyte 1 alpha-hydroxylase in renal failure.Am J Physiol1995; 268: F746–53.
21.
NormanA.W.. Minireview: vitamin D receptor: new assignments for an already busy receptor.Endocrinology2006; 147: 5542–8.
22.
ErbenR.G., SoegiartoD.W., WeberK.. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.Mol Endocrinol2002; 16: 1524–37.
23.
BouillonR., CarmelietG., VerlindenL.. Vitamin D and human health: lessons from vitamin D receptor null mice.Endocr Rev2008; 29: 726–76.
24.
BrownA.J., FinchJ., SlatopolskyE.. Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport.J Lab Clin Med2002; 139: 279–84.
25.
KurnikBR, and HruskaK.A.. Mechanism of stimulation of renal phosphate transport by 1,25-dihydroxycholecalciferol.Biochim Biophys Acta1985; 817: 42–50.
26.
PandaD.K., MiaoD., BolivarI.. Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis.J Biol Chem2004; 279: 16754–66.
SchwarzU., AmannK., OrthS.R., SimonavicieneA., WesselsS., RitzE.. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats.Kidney Int1998; 53: 1696–705.
29.
CozzolinoM., BrancaccioD., GallieniM., GalassiA., SlatopolskyE., DussoA.. Pathogenesis of parathyroid hyperplasia in renal failure.J Nephrol2005; 18: 5–8.
30.
CozzolinoM., LuY., FinchJ., SlatopolskyE., DussoA.S.. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.Kidney Int2001; 60: 2109–17.
31.
DussoA., CozzolinoM., LuY., SatoT., SlatopolskyE.. 1,25-Dihydroxyvitamin D downregulation of TGFα/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.J Steroid Biochem Mol Biol2004, 89–90: 507–11.
32.
LinR., WhiteJ.H.. The pleiotropic actions of vitamin D.Bioessays2004; 26: 21–8.
33.
NagpalS., NaS., RathnachalanR.. Noncalcemic actions of vitamin D receptor ligands.Endocrine Rev2005; 26: 662–87.
34.
YangS., SmithC., PrahlJ.M., DeLucaH.F.. Vitamin D deficiency suppresses cell-mediated immunity in vivo.Arch Biochem Biophys1993; 303: 98–106.
35.
CantornaM.T., HayesC.E., DeLucaH.F.. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.Proc Natl Acad Sci USA1996; 93: 7861–4.
36.
ZellaJ.B., DeLucaH.F.. Vitamin D and autoimmune diabetes.J Cell Biochem2003; 88: 216–22.
37.
HullettD.A., CantornaM.T., RedaelliC.. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.Transplantation1998; 66: 824–8.
38.
CegliaL.. Vitamin D and skeletal muscle tissue and function.Mol Aspects Med2008; 29: 407–14.
39.
MartiniL.A., WoodR.J.. Vitamin D and blood pressure connection: update on epidemiologic, clinical, and mechanistic evidence.Nutr Rev2008; 66: 291–7.
40.
LiY.C., KongJ., WeiM., ChenZ.F., LiuS.Q., CaoL.P.. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system.J Clin Invest2002; 110: 229–38.
41.
SimpsonR.U., HersheyS.H., NibbelinkK.A.. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse.J Steroid Biochem Mol Biol2007; 103: 521–4.
